Somatic BRCA1/2 mutations occur at some frequency in sporadic ovarian and prostate cancers; however, they are not necessarily accompanied by the inactivation of the remaining allele, and, hence, sensitivity to PARPis [113,115,116]. The gene discussed is BRCA1; the disease is prostate cancer.